Analysts Offer Insights on Services Companies: CSX Corp (CSX), CarMax (KMX) and UnitedHealth (UNH)


Companies in the Services sector have received a lot of coverage today as analysts weigh in on CSX Corp (CSX), CarMax (KMX) and UnitedHealth (UNH).

CSX Corp (CSX)

Morgan Stanley analyst Ravi Shanker maintained a Sell rating on CSX Corp today and set a price target of $57. The company’s shares opened today at $79.40, close to its 52-week high of $80.28.

According to TipRanks.com, Shanker is a 3-star analyst with an average return of 1.4% and a 56.9% success rate. Shanker covers the Services sector, focusing on stocks such as Expeditors International, Echo Global Logistics, and Old Dominion Freight.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CSX Corp with a $82 average price target.

See today’s analyst top recommended stocks >>

CarMax (KMX)

In a report released today, Armintas Sinkevicius from Morgan Stanley maintained a Buy rating on CarMax, with a price target of $93. The company’s shares opened today at $76.70.

According to TipRanks.com, Sinkevicius is a 2-star analyst with an average return of 0.5% and a 50.8% success rate. Sinkevicius covers the Industrial Goods sector, focusing on stocks such as Magna International, Tenneco Automotive, and American Axle.

Currently, the analyst consensus on CarMax is a Strong Buy with an average price target of $77.80, representing a 1.4% upside. In a report released today, Oppenheimer also assigned a Buy rating to the stock.

UnitedHealth (UNH)

Morgan Stanley analyst Zachary Sopcak maintained a Buy rating on UnitedHealth today and set a price target of $285. The company’s shares opened today at $223.79.

According to TipRanks.com, Sopcak is a 3-star analyst with an average return of 2.7% and a 41.4% success rate. Sopcak covers the Services sector, focusing on stocks such as Community Health, Centene Corp, and Humana Inc.

Currently, the analyst consensus on UnitedHealth is a Strong Buy with an average price target of $292.11, implying a 30.5% upside from current levels. In a report released yesterday, Oppenheimer also maintained a Buy rating on the stock with a $305 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts